Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Authorisation Safety Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training in Europe

NCT04773015 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT04773015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04773015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Authorisation Safety Study to Evaluate the Effectiveness of VIZAMYL™ Reader Training in Europe
Lead sponsor
GE Healthcare
Phase
Observational
Overall status
Completed
Start date
December 11, 2018
Completion date
December 7, 2021
Enrollment
227 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment